# Monitoring Minimal Residual Disease（MRD）in Pediatric B-acute Lymphoblastic Leukemia

> **NCT04977895** · — · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 255 (estimated)

## Conditions studied

- B Acute Lymphoblastic Leukemia

## Interventions

- **DIAGNOSTIC_TEST:** Minimal residual disease (MRD) monitoring

## Key facts

- **NCT ID:** NCT04977895
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-30
- **Primary completion:** 2024-01-30
- **Final completion:** 2026-01-30
- **Target enrollment:** 255 (ESTIMATED)
- **Last updated:** 2021-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04977895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04977895, "Monitoring Minimal Residual Disease（MRD）in Pediatric B-acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04977895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*